De Ronde H - Search Results

1

Preeclampsia and genetic risk factors for thrombosis: a case-control study.

De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oei SG, Kanhai HH, Rosendaal FR. De Groot CJ, et al. Among authors: de ronde h. Am J Obstet Gynecol. 1999 Oct;181(4):975-80. doi: 10.1016/s0002-9378(99)70335-2. Am J Obstet Gynecol. 1999. PMID: 10521764

2

Venous thrombotic risk in family members of unselected individuals with factor V Leiden.

Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Lensen RP, et al. Among authors: de ronde h. Thromb Haemost. 2000 Jun;83(6):817-21. Thromb Haemost. 2000. PMID: 10896231

3

Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria.

de Ronde H, Bertina RM. de Ronde H, et al. Thromb Haemost. 1994 Dec;72(6):880-6. Thromb Haemost. 1994. PMID: 7740458

4

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Koster T, et al. Among authors: de ronde h. Lancet. 1993 Dec 18-25;342(8886-8887):1503-6. doi: 10.1016/s0140-6736(05)80081-9. Lancet. 1993. PMID: 7902898

5

Mutation in blood coagulation factor V associated with resistance to activated protein C.

Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Bertina RM, et al. Among authors: de ronde h. Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0. Nature. 1994. PMID: 8164741 Free article.

6

Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients.

Lensen RP, Rosendaal FR, Koster T, Allaart CF, de Ronde H, Vandenbroucke JP, Reitsma PH, Bertina RM. Lensen RP, et al. Among authors: de ronde h. Blood. 1996 Dec 1;88(11):4205-8. Blood. 1996. PMID: 8943855 Free article.

7

The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction.

Haan J, Kappelle LJ, de Ronde H, Ferrari MD, Bertina RM. Haan J, et al. Among authors: de ronde h. Cephalalgia. 1997 Aug;17(5):605-7. doi: 10.1046/j.1468-2982.1997.1705605.x. Cephalalgia. 1997. PMID: 9251878

8

Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation.

de Ronde H, Bertina RM. de Ronde H, et al. Blood Coagul Fibrinolysis. 1999 Jan;10(1):7-17. doi: 10.1097/00001721-199901000-00002. Blood Coagul Fibrinolysis. 1999. PMID: 10070830

9

Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.

Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J. Curvers J, et al. Among authors: de ronde h. Thromb Haemost. 2002 Mar;87(3):483-92. Thromb Haemost. 2002. PMID: 11924538

10

Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation.

Legnani C, Palareti G, Biagi R, Coccheri S, Bernardi F, Rosendaal FR, Reitsma PH, de Ronde H, Bertina RM. Legnani C, et al. Among authors: de ronde h. Br J Haematol. 1996 Jun;93(3):694-9. doi: 10.1046/j.1365-2141.1996.d01-1709.x. Br J Haematol. 1996. PMID: 8652396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters